EDRN Scientific Workshop, March 6-8, 2018 Presentations
- 3-8-2018: EDRN-MCL-14-Collaborative Discussion Between EDRN and MCL
- 3-6-2018: FDA Workshop-10-Schetter "Regulatory Considerations for In Vitro Diagnostic Multivariate Index Assays (IVDMIA)"
- 3-8-2018: EDRN-MCL-10-Dubinett-"Immunity and Inflammation in the Pathogenesis of Lung Cancer"
- 3-6-2018: Scientific Workshop-08-Hanash "The Continuum of Risk Assessment and Early Detection through Blood Based Biomarkers"
- 3-8-2018: EDRN-MCL-07-Weaver-"Prediction of Progression and Recurrence in the Vermont Cohort of Screen-detected Breast Cancer"
- 1: 10th EDRN Scientific Workshop Main Agenda
- 3-7-2018: Scientific Workshop-12-Pollack "Consortium for Imaging & Biomarkers U01: Early Detection of Aggressive Cancer"
- 3-6-2018: FDA Workshop-11-Skates "Summary-FDA Meeting"
- 3-7-2018: Scientific Workshop-13-Park-Wolpin "Pancreatic Cancer Detection Consortium (PCDC)"
- 3-8-2018: EDRN-MCL-08-Paulovich-"Unique Approach Combining Avatar Mice and Targeted Mass Spectrometry to Identify Blood Biomarkers for Early Detection of Breast Cancer"
- 3-6-2018: Scientific Workshop-09-Zhang "By Design Approach in Biomarker Development, Validation, and Clinical Implementation"
- 3-8-2018: EDRN-MCL-09-Anderson-"Breast Cancer: Integrating Imaging and Molecular Diagnostics"
- 3-7-2018: Scientific Workshop-14-Pandol "Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer"
- 3-7-2018: Scientific Workshop-06-Gazdar "High and Low Neuroendocrine subtypes of Small Cell Lung Cancer and their Clinical Significance"
- 3-6-2018: Scientific Workshop-10-Wei "Challenges in Moving Biomarkers from Bench to Bedside"
- 3-6-2018: Scientific Workshop-01-Kramer "Opening Remarks"
- 3-7-2018: Scientific Workshop-15-Kenner "World Pancreatic Coalition 2018"
- 3-7-2018: Scientific Workshop-07-Stoyanova "Deciphering Prostate Cancer Heterogeneity – Radiogenomics of Tumor Habitats"
- 3-7-2018: Scientific Workshop-16-Crosby "Cancer Research UK Strategy and Activities in Early Detection Research"
- 3-6-2018: Scientific Workshop-02-Srivastava "Welcome and Charge to Participants"
- 3-6-2018: Scientific Workshop-11-Spira "From Bench to Boardroom to Bedside: An Airway Gene-expression Biomarker’s 15-year Journey"
- 3-6-2018: Scientific Workshop-03-Sharpless "Impressions of a New NCI Director"
- 3-6-2018: FDA Workshop-01-Srivastava "Joint EDRN-FDA Scientific Workshop Biomarkers in Precision Medicine"
- 3-7-2018: Scientific Workshop-08-Aberle "Approaches to Characterization of Indeterminate Lung Nodules"
- 3-7-2018: Scientific Workshop-01-Meyerson "What Makes a Neoplasm Malignant or Benign? Is It in the Genes?"
- 3-6-2018: Scientific Workshop-04-Esener "A Review of Seed Investments at the Knight Cancer Institute For Early Detection Research"
- 3-6-2018: FDA Workshop-04-Pathak "The FDA/CDRH Pre-Submission Program"
- 3-7-2018: Scientific Workshop-09-Koay "Multiparametric Image Processing for Early Detection of Cancer"
- 3-6-2018: FDA Workshop-02-Skates "Topic #1-EDRN FDA Meeting"
- 3-7-2018: Scientific Workshop-10-Seewaldt "Biomarkers: Challenges and Strategies for Early Detection of Biologically Aggressive Breast Cancer"
- 3-6-2018: FDA Workshop-03-Seidman "How Can We Reduce Mortality from Ovarian Cancer?"
- 3-6-2018: Scientific Workshop-05-Kinzler "Liquid Biopsy for the Early Detection of Cancer"
- 3-8-2018: EDRN-MCL-01-Mansfield-"Development of Early Cancer Detection Tests Based on Sequencing of Cell-Free Nucleic Acids"
- 3-8-2018: EDRN-MCL-11-Schabath-"Radiomic Models Distinguish Indolent versus Aggressive Lung Cancers"
- 3-8-2018: EDRN-MCL-04-Semmes-"A Targeted Proteomics Strategy for the Development of Prostate Cancer Liquid-Biopsies"
- 3-6-2018: FDA Workshop-05-Ransohoff "How to Get Biomarkers for Cancer Screening into Clinical Practice: Use of Banked Samples from Cohorts"
- 3-7-2018: Scientific Workshop-11-Gillies "Radiomics in Early Detection of Lung Cancers"
- 3-6-2018: FDA Workshop-07-Chan "FDA Requirements for Technology Platform Approval Clearance-Proteomics and Mass Spectrometry"
- 3-7-2018: Scientific Workshop-03-Skates "Proteomic and Genomic Ovarian Cancer Biomarker Discovery and Validation"
- 3-6-2018: Scientific Workshop-06-Grundberg "Multiplex Screening and Evaluation of Plasma Protein Biomarkers for Early Detection of Colorectal Cancer Using Proximity Extension Assay"
- 3-6-2018: FDA Workshop-08-Jeffery "FDA Recommendations for Platform Approval/Clearance, with a Focus on Proteomics and Mass Spectrometry"
- 3-8-2018: EDRN-MCL-02-Brooks-"Genomic and Proteomic Studies of Prostate Cancer Evolution"
- 3-8-2018: EDRN-MCL-12-Showe-"Whole Blood Gene Expression Can Accurately Distinguish Benign From Malignant Lung Nodules; Transitioning From Microarrays To The NanoString™ Platform"
- 3-8-2018: EDRN-MCL-05-Sanda-"Interrogating the Urinary Transcriptome To Refine Prostate Cancer Detection"
- 3-6-2018: FDA Workshop-06-Pennello "Can an In Vitro Diagnostic (IVD) Device be Validated for Early Detection on Banked Samples?"
- 3-6-2018: Scientific Workshop-07-Bornhop "Biomarker Quantification by Compensated Interferometry: Lowering the LOQ to Improve Case-Control Separation for IPNs"
- 3-6-2018: FDA Workshop-09-Zhang "FDA Requirements for Analyte Panel and Classifier Approval/Clearance: Guidance and Drivers in IVDMIA Development"
- 3-7-2018: Scientific Workshop-04-Singhi "Early Detection of Pancreatic Cancer through the Evaluation of Pancreatic Cysts"
- 3-8-2018: EDRN-MCL-13-Herman-"Approaches to Improving DNA Methylation Detection Meeting the Requirements for Early Detection"
- 3-8-2018: EDRN-MCL-06-Esserman-"Understanding the Landscape of DCIS"
- 3-7-2018: Scientific Workshop-05-Tomlins "Prostate Cancer as a Model for the Challenges of Precision Early Detection"